215 related articles for article (PubMed ID: 22294488)
1. The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer.
Gravgaard KH; Lyng MB; Laenkholm AV; Søkilde R; Nielsen BS; Litman T; Ditzel HJ
Breast Cancer Res Treat; 2012 Jul; 134(1):207-17. PubMed ID: 22294488
[TBL] [Abstract][Full Text] [Related]
2. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
Wang B; Li J; Sun M; Sun L; Zhang X
IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
[TBL] [Abstract][Full Text] [Related]
3. A miRNA signature associated with human metastatic medullary thyroid carcinoma.
Santarpia L; Calin GA; Adam L; Ye L; Fusco A; Giunti S; Thaller C; Paladini L; Zhang X; Jimenez C; Trimarchi F; El-Naggar AK; Gagel RF
Endocr Relat Cancer; 2013 Dec; 20(6):809-23. PubMed ID: 24127332
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
[TBL] [Abstract][Full Text] [Related]
5. Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis.
Pizzini S; Bisognin A; Mandruzzato S; Biasiolo M; Facciolli A; Perilli L; Rossi E; Esposito G; Rugge M; Pilati P; Mocellin S; Nitti D; Bortoluzzi S; Zanovello P
BMC Genomics; 2013 Aug; 14():589. PubMed ID: 23987127
[TBL] [Abstract][Full Text] [Related]
6. MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways.
Li X; Roslan S; Johnstone CN; Wright JA; Bracken CP; Anderson M; Bert AG; Selth LA; Anderson RL; Goodall GJ; Gregory PA; Khew-Goodall Y
Oncogene; 2014 Jul; 33(31):4077-88. PubMed ID: 24037528
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma.
Kurashige J; Kamohara H; Watanabe M; Hiyoshi Y; Iwatsuki M; Tanaka Y; Kinoshita K; Saito S; Baba Y; Baba H
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S656-64. PubMed ID: 22311119
[TBL] [Abstract][Full Text] [Related]
8. BMP-6 inhibits microRNA-21 expression in breast cancer through repressing deltaEF1 and AP-1.
Du J; Yang S; An D; Hu F; Yuan W; Zhai C; Zhu T
Cell Res; 2009 Apr; 19(4):487-96. PubMed ID: 19308091
[TBL] [Abstract][Full Text] [Related]
9. Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers.
van Schooneveld E; Wouters MC; Van der Auwera I; Peeters DJ; Wildiers H; Van Dam PA; Vergote I; Vermeulen PB; Dirix LY; Van Laere SJ
Breast Cancer Res; 2012 Feb; 14(1):R34. PubMed ID: 22353773
[TBL] [Abstract][Full Text] [Related]
10. Identification of lymph node metastasis-related microRNAs in lung adenocarcinoma and analysis of the underlying mechanisms using a bioinformatics approach.
Yan L; Jiao D; Hu H; Wang J; Tang X; Chen J; Chen Q
Exp Biol Med (Maywood); 2017 Apr; 242(7):709-717. PubMed ID: 28299977
[TBL] [Abstract][Full Text] [Related]
11. Global microRNA profiling of metastatic conjunctival melanoma.
Mikkelsen LH; Andersen MK; Andreasen S; Larsen AC; Tan Q; Toft PB; Wadt K; Heegaard S
Melanoma Res; 2019 Oct; 29(5):465-473. PubMed ID: 30932942
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-to-mesenchymal transition (EMT) in intraductal papillary mucinous neoplasm (IPMN) is associated with high tumor grade and adverse outcomes.
Lahat G; Lubezky N; Loewenstein S; Nizri E; Gan S; Pasmanik-Chor M; Hayman L; Barazowsky E; Ben-Haim M; Klausner JM
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S750-7. PubMed ID: 25069861
[TBL] [Abstract][Full Text] [Related]
13. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
[TBL] [Abstract][Full Text] [Related]
15. The role of microRNA-200 in progression of human colorectal and breast cancer.
Bojmar L; Karlsson E; Ellegård S; Olsson H; Björnsson B; Hallböök O; Larsson M; Stål O; Sandström P
PLoS One; 2013; 8(12):e84815. PubMed ID: 24376848
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of microRNAs involved in epithelial-mesenchymal transition of HT-29 cell line.
Cai ZG; Zhang SM; Zhang H; Zhou YY; Wu HB; Xu XP
Cell Biol Int; 2013 Jul; 37(7):669-74. PubMed ID: 23483606
[TBL] [Abstract][Full Text] [Related]
17. Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma.
Castilla MÁ; Moreno-Bueno G; Romero-Pérez L; Van De Vijver K; Biscuola M; López-García MÁ; Prat J; Matías-Guiu X; Cano A; Oliva E; Palacios J
J Pathol; 2011 Jan; 223(1):72-80. PubMed ID: 21125666
[TBL] [Abstract][Full Text] [Related]
18. miR-200 enhances mouse breast cancer cell colonization to form distant metastases.
Dykxhoorn DM; Wu Y; Xie H; Yu F; Lal A; Petrocca F; Martinvalet D; Song E; Lim B; Lieberman J
PLoS One; 2009 Sep; 4(9):e7181. PubMed ID: 19787069
[TBL] [Abstract][Full Text] [Related]
19. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
[TBL] [Abstract][Full Text] [Related]
20. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q
Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]